How much dividend does Poxel pay?
Over the past 12 months, Poxel paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Poxel is expected to pay a dividend of 0 EUR.
Poxel Dividend 2024
Poxel Dividend
0 EUR
Poxel Dividend yield
Ticker
POXEL.PA
ISIN
FR0012432516
WKN
A14M04
How much dividend does Poxel 2024 pay?
According to the latest status from October 2024, Poxel paid a total of 0 EUR per share in dividends within the last 12 months. With the current Poxel price of 0.35 EUR, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical Poxel Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the Poxel Dividend Safe?
Poxel has been increasing the dividend for 0 years.
Over the past 10 years, Poxel has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding Poxel's Dividend Distributions
Poxel’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Poxel's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Poxel's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Poxel’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Poxel Aktienanalyse
What does Poxel do?
Poxel SA is a biopharmaceutical company focused on developing drugs for the treatment of metabolic disorders, particularly type 2 diabetes. The company was founded in Lyon, France, in 2009. Poxel SA's business model is based on the targeted development of drugs for the treatment of metabolic disorders with high medical demand and large market potential. The company focuses on identifying drug candidates that are highly specific and effective while also having a favorable safety profile. Poxel SA collaborates closely with academic research and the industry to leverage the latest knowledge and technologies in drug development. Over the years, Poxel SA has become a leading company in metabolism medicine, with an extensive product pipeline of promising drug candidates. The product range includes both preclinical and clinical candidates, as well as products in advanced stages of clinical development. One of Poxel SA's main products is Imeglimin, a drug for the treatment of type 2 diabetes. Imeglimin is a new active ingredient that acts on the metabolic disorder in a novel way and improves the body's glucose metabolism. The drug is currently in the final phase of clinical development and has shown promising results in previous studies. Another promising product from Poxel SA is PXL770, a drug for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). PXL770 is a novel active ingredient that acts on the body's AMP-activated protein kinase system and regulates lipid and glucose metabolism. The drug is still in the clinical development phase but has already shown promising results. Another promising product group from Poxel SA are the adenosine monophosphate (AMP) activators, which are also being developed for the treatment of metabolic disorders such as type 2 diabetes and fatty liver disease. The AMP activators act on the body's AMP-activated protein kinase system and regulate lipid and glucose metabolism. Poxel SA also works closely with partners in the pharmaceutical industry to develop and bring innovative drug candidates to the market. The company has partnerships with leading companies such as Sumitomo Dainippon Pharma, Roivant Sciences, and Servier to expand and diversify its product pipeline. Overall, Poxel SA is an emerging company in metabolism medicine, focusing on the development of innovative drugs for the treatment of metabolic disorders. With a strong product pipeline and proven collaboration with academia and the industry, Poxel SA is a promising player in this growing market. Poxel is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Poxel stock can be added to a savings plan with the following providers: Trade Republic
Frequently Asked Questions about Poxel stock
What is the dividend yield of Poxel?
The current dividend yield of Poxel is .
When does Poxel pay dividends?
Poxel pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Poxel?
Poxel paid dividends every year for the past 0 years.
What is the dividend of Poxel?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Poxel located?
Poxel is assigned to the 'Health' sector.
Wann musste ich die Aktien von Poxel kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Poxel from 10/4/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Poxel pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Poxel in the year 2023?
In the year 2023, Poxel distributed 0 EUR as dividends.
In which currency does Poxel pay out the dividend?
The dividends of Poxel are distributed in EUR.
Andere Kennzahlen von Poxel
Our stock analysis for Poxel Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Poxel Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
